Keywords: UK. NICE, Skin cancer, Roche, Zelboraf, Bristol-Myers, Yervoy

UK's NICE plans to back NHS use of two breakthrough skin cancer treatments

Article | 01 November 2012

Print This

The UK’s drugs watchdog the National Institute for Health and Clinical Excellence (NICE) this morning (November 2) issued ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in